• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Long-term effect of ischaemic postconditioning on recovery of left ventricular contractile function

Long-term effect of ischaemic postconditioning on recovery of left ventricular contractile function

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户：yocar
【摘 要】
：
Background Ischemic postconditioning has been reported to reduce infarct size in patients with ST-segment-elevation myocardial infarction.However,the long-term cardioprotective effects of postconditio
【作 者】
：
Lye Yuxuan QiXiaoyong Dang Yi Li Yingxiao Yuan Huabing Wang Tianhong Liu Huiliang Di Qian Zhang Feifei 
【机 构】
：
Hebei General Hospital,Hebei,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
【发表日期】
：
2014年3期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Ischemic postconditioning has been reported to reduce infarct size in patients with ST-segment-elevation myocardial infarction.However,the long-term cardioprotective effects of postconditioning on recovery of left ventricular contractile function have not been demonstrated
其他文献
Picroside Ⅱ protects cardiomyocytes from hypoxia/reoxygenation-induced apoptosis by activating the P
Background Picroside Ⅱ,an iridoid glucoside found in the root of Picrorhiza scrophulariiflora Pennell (Scrophulariaceae),has been demonstrated to reduce apoptosis in neuronal cells and other cell type
会议
Association between glomerular filtration rate and stroke in hypertensive patients in rural areas of
Background The present study is to explore the association between estimated glomerular filtration rate (eGFR) and stroke in hypertensive patients in rural areas of China.Methods The prospective study
会议
Secondary prevention for patients with acute coronary syndrome after percutaneous coronary intervent
Background This study was to investigate the status of secondary prevention in patients with acute coronary syndrome received percutaneous coronary intervention (PCI) during hospitalization and after
会议
Association between obesity and ECG variables in children and adolescents:a cross sectional study
Background Obesity exhibits a wide variety of electrocardiogram (ECG) abnormalities in adults,which often lead to cardiovascular events.However,there is currently no evidence of an association between
会议
Clinical feature and ambulatory blood pressure monitoring feature of patients with white-coat resist
Background This study was to compare clinical and ambulatory blood pressure monitoring features of the patients with resistant hypertension,to analyze clinical and ambulatory blood pressure monitoring
会议
Basal metabolic rate with risk of the rate of carotid artery plaque in Uygur,Kazakh and Han populati
Background This study was to investigate association of basal metabolic rate with risk of the Rate of carotid artery plaque in Uygur,Kazakh and Han populations of Xinjiang.Methods During the period of
会议
Long-term effects of three different therapeutic strategies in patients with myocardial infarction p
Background This study was a prospective clinical trial designed to compare intensive medical treatment,primary stent placement (PCI),and surgical myocardial revascularization (CABG) for patients with
会议
Improved biocompatibility of poly(lactic-co-glycolic acid) and poly-L-lactic acid blended with nanop
Background Biodegradable polymers used as vascular stent coatings and stent platforms encounter a major challenge: biocompatibility in vivo,which plays an important role in in-stent restenosis (ISR).C
会议
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
会议
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent
Background TARGET Ⅰ randomized controlled trial demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was non-in
会议